Literature DB >> 12055244

Characterization of mouse and human B7-H3 genes.

Mingyi Sun1, Sabrina Richards, Durbaka V R Prasad, Xoi Muoi Mai, Alexander Rudensky, Chen Dong.   

Abstract

T cell activation and immune function are regulated by costimulatory molecules of the B7 superfamily. Human B7-H3 is a recent addition to this family and has been shown to mediate T cell proliferation and IFN-gamma production. In this work we describe the identification of the mouse B7-H3 homolog, which is ubiquitously expressed in a variety of tissues. Activated CD4 and CD8 T cells express a putative receptor that can be recognized by soluble mouse B7-H3-Ig molecules. While the mouse B7-H3 gene was found to contain a single copy, we discovered a novel isoform of human B7-H3 (named as B7-H3b hereafter) with four Ig-like domains that results from gene duplication and differential splicing. B7-H3b is the major isoform expressed in several tissues. This structural information suggests a genetic variation of the B7-H3 gene in mammalian species.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055244     DOI: 10.4049/jimmunol.168.12.6294

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  104 in total

Review 1.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

Review 2.  Immunology of B7-H1 and its roles in human diseases.

Authors:  Hideto Tamura; Kiyoyuki Ogata; Haidong Dong; Lieping Chen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

3.  B7x: a widely expressed B7 family member that inhibits T cell activation.

Authors:  Xingxing Zang; P'ng Loke; Jayon Kim; Kenneth Murphy; Rebecca Waitz; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-14       Impact factor: 11.205

4.  Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis.

Authors:  Roberta Castriconi; Alessandra Dondero; Raffaella Augugliaro; Claudia Cantoni; Barbara Carnemolla; Angela Rita Sementa; Francesca Negri; Romana Conte; Maria Valeria Corrias; Lorenzo Moretta; Alessandro Moretta; Cristina Bottino
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

5.  BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation.

Authors:  Thang Nguyen; Xikui K Liu; Yongliang Zhang; Chen Dong
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

6.  The immunomodulatory proteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placenta.

Authors:  Margaret G Petroff; Elza Kharatyan; Donald S Torry; Lesya Holets
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

7.  T-cell tolerance or function is determined by combinatorial costimulatory signals.

Authors:  Roza Nurieva; Sunil Thomas; Thang Nguyen; Natalia Martin-Orozco; Ying Wang; Murali-Krishna Kaja; Xue-Zhong Yu; Chen Dong
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

8.  Murine b7-h3 is a co-stimulatory molecule for T cell activation.

Authors:  Ruhong Yan; Shun Yang; Aiping Gu; Fuqin Zhan; Chunyan He; Chenhao Qin; Xueguang Zhang; Ping Feng
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2013-12

9.  Structure and T cell inhibition properties of B7 family member, B7-H3.

Authors:  Vladimir Vigdorovich; Udupi A Ramagopal; Eszter Lázár-Molnár; Eliezer Sylvestre; Jun Sik Lee; Kimberly A Hofmeyer; Xingxing Zang; Stanley G Nathenson; Steven C Almo
Journal:  Structure       Date:  2013-04-11       Impact factor: 5.006

10.  Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.

Authors:  Sangbin Lim; Hao Liu; Luciana Madeira da Silva; Ritu Arora; Zixing Liu; Joshua B Phillips; David C Schmitt; Tung Vu; Steven McClellan; Yifeng Lin; Wensheng Lin; Gary A Piazza; Oystein Fodstad; Ming Tan
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.